![Graham McNeil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Graham McNeil
Vorsitzender bei Bristol-Myers Squibb FCT bêta, Inc.
Profil
Graham McNeil is currently the Chairman at Bristol-Myers Squibb FCT bêta, Inc. He has a graduate degree from the University of Toronto.
Aktive Positionen von Graham McNeil
Unternehmen | Position | Beginn |
---|---|---|
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Vorsitzender | 09.08.2021 |
Ausbildung von Graham McNeil
University of Toronto | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Bristol-Myers Squibb FCT bêta, Inc.
![]() Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | Health Technology |